NTV reports on PrEPVacc's first enrolments

Uganda has started an efficacy trial of an HIV vaccine for the purposes of testing if it can prevent HIV infection, reports NTV Uganda.

Uganda has started an efficacy trial of an HIV vaccine for the purposes of testing if it can prevent HIV infection. #NTVNews pic.twitter.com/ORDAZZxZ7X

— NTV UGANDA (@ntvuganda) December 16, 2020

The vaccine known as PrepVacc is a phase 3 trial using a combination of two drugs meant to test two ways of preventing HIV in the body. According to the Uganda Virus research Institute, which is leading the trials, the process started on Tuesday at their site in Masaka. #NTVNews

— NTV UGANDA (@ntvuganda) December 16, 2020